CFOROTCServices-Medical LaboratoriesFiscal year ends December 31
CapForce Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$4.03+0.53 (+15.14%)
Close on Oct 19, 2026
- Market cap
- $50.33M
- P/E (TTM)
- 0.7
- Dividend yield
- –
Share price
+$4.03 (+4,029,900%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
CapForce Inc. reported revenue of $76.20M for the twelve months to Jun 30, 2026. Free cash flow was -$1.23M.
Revenue
$76.20M
TTM Q2 2026
Operating income
$64.63M
TTM Q2 2026
Free cash flow
-$1.23M
FY2025
EPS, diluted
$5.38
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $50.33M
- P/E ratio
- 0.7
- Price to sales
- 0.66
- Price to book
- 0.68
- Dividend yield
- –
- Free cash flow yield
- -2.45%
Fundamentals
- Revenue
- $76.20M
- Net income
- $62.28M
- EPS, diluted
- $5.38
- Free cash flow
- -$1.23M
- Book value per share
- $5.95
- Diluted shares
- 12M
Thirteen years at a glance
Fiscal years 2013 to 2025 and trailing twelve months, USD
Revenue
$76.20M
Gross profit
–
Operating income
$64.63M
Net income
$62.28M
EPS, diluted
$5.38
Free cash flow
–
Reported periodTrailing twelve months